This global, observational study evaluated population-based interferon-gamma release assay (IGRA) status - a measure of TB infection (TBI), as a proxy for TB incidence to identify trial sites in high-incidence areas.<h4>Methods</h4>Participants (15-34 years) were recruited from 45 sites in 14 countries. Here, IFNG is linked to tuberculosis.